Similarly, in patients with ovarian cancer carrying p53 mutations, the median survival time was 60 weeks for tumors with high levels of SIRT7 and 30 weeks for tumors with low levels of SIRT7 (Figure 4B). Here, TP53 is linked to ovarian carcinoma.